The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder by SHARIF, Mohammad Reza et al.
48 Iran J Child Neurol. 2015 AutumN  Vol 9 No 4
The Relationship between Serum Vitamin D Level and Attention Deficit 
Hyperactivity Disorder
1.Department of Pediatrics, Kashan 
University of Medical Sciences, 
Kashan, Iran
2.Student of Research Committee, 
Kashan University of Medical 
Sciences, Kashan, Iran
3.Isfahan Endocrine & Metabolism 
Research Center, Isfahan University of 
Medical Sciences, Isfahan, Iran
4.Department of Clinical Psychology, 




Student of Research Committee, 
Kashan University of Medical 
Sciences, Kashan, Iran
Tel: +98 31 55540026






How to Cite This Article: Sharif MR, Madani M, Tabatabaei F, Tabatabaee Z. The Relationship between Serum Vitamin D Levels and 
Attention Deficit Hyperactivity Disorder. Iran J Child Neurol. Autumn 2015;9(4): 48-53.
Introduction
Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent mental 
health disorders that affect about 5.3–7.1 percent of children and adolescents (1). 
Attention deficiency, hyperactivity and impulsivity are three main symptoms that 
help diagnose the disorder before the age of twelve years (1, 2). Besides, other 
accompanying secondary symptoms such as aggression, social incompetence, 
conflict with peers and anti-social behavior other clinically important symptoms (2, 
3). 
So far, drug therapy is the main treatment method. However, there are limitations in 
drug interventions. For instance, 30 percent of ADHD children do not respond to the 
drug treatment (4, 5). More effective treatment and strategies are needed to control 
the disease (6, 7). In recent years, the role of environment (8-10) and more specifically 
the role of nutrition in the prevention and treatment of the symptoms of the disease 
have been attracting the attention of researchers (11-13). Diet therapy is a simple 
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Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent 
mental health disorders. In recent years, the impacts of various micronutrients 
on ADHD have been studied. However, vitamin D has received much less 
attention. This study was aimed at evaluating the association and level of 
serum vitamin D in children with ADHD. 
Materials & Methods
This case-control study was carried out, in 2012, on 6 to 12 yr-old children. 
Thirty-seven were children with ADHD in the cases group and another 37 
healthy children were in the control group. Venous blood sample was drawn 
from each child to measure the serum level of vitamin D. Other variables were 
compared as well. 
Results
The mean serum vitamin D level of children with ADHD (19.11±10.10 ng/ml) was 
significantly lower than that of the control group (28.67±13.76 ng/ml) (P<0.001). 
Conclusion
Deficiency of vitamin D has been proved in various psychiatric diseases. This 
study evidenced a significantly low level of serum vitamin D in children with 
ADHD. This suggests the need for regularly monitoring of serum vitamin D 
levels and treatment of patients with vitamin D deficiencies. 
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and inexpensive method that can be readily accepted 
by the parents and adopted by the children. Nutrition 
therapy, especially the role of supplements and vitamins 
is very pronounced (11). The role of micronutrients such 
as iron (14-16), zinc (17, 18) and omega three (19) on 
the prevention and control of the symptoms have been 
extensively studied. However, the role of vitamin D has 
attracted less attention. This condition exists despite 
the fact that vitamin D deficiency is associated with 
psychiatric diseases such as autism, schizophrenia, and 
depression (20-22). This vitamin is not only involved in 
bone metabolism and serum calcium regulation but also 
has significant effect on many body organs (23). 
Thus, it has been recommended that the level of this 
vitamin should be checked in pregnant women and their 
babies (20, 24). Vitamin D deficiency during the fetal 
period is accounted for some psychological disorders 
after birth (21). In addition, it has been suggested that 
vitamin D insufficiency during the fetal and post-natal 
period has unfavorable effects on the development of the 
brain structure and functions (20). 
This study was designed to examine serum vitamin D 
level of children diagnosed to have ADHD.
Materials & Methods
This case-control study was carried out in 2012. Healthy 
children and children diagnosed to have ADHD in the age 
range of 6 to 12 year-old were eligible to enter the study. 
Overall, following the completion of consent form, 74 
children voluntarily participated in the study. The case 
group (n=37) included children who had ADHD medical 
records at a pediatric psychiatric clinic in Isfahan and 
the control group (n=37) among non ADHD children 
selected from those who were referred to health centers 
for checking their weight and height. Their demographic 
data were collected at the time of referral. 
A psychiatrist has ruled out the ADHD and diagnosis was 
made based on facts from a face-to-face interview with 
the child and his parents and using the Statistical Manual 
of Mental Disorders Diagnostic (DSM-IV) criteria (25). 
After confirming the diagnosis of ADHD, a child would 
enter the study protocol. A child who suffered from liver, 
kidney or any endocrine disease or who was on vitamin 
D supplement was excluded from the study. Besides, a 
child diagnosed to have mental retardation, autism or 
seizures was excluded. Parents were explained about the 
safety and purpose of the study and about confidentiality 
of every child’s data. 
This study was approved by Ethic Committee of Kashan 
University of Medical Science. After obtaining written 
informed consent from each participant’s parent, three 
milliliter (ml) of venous blood was drawn from each 
child in both the cases and control groups. Standard DIA 
source kit and ELISA methods were used to measure 
the level of 25-hydroxi vitamin D. The serum vitamin 
D level was classified as severely low (< 10 nanograms 
(ng) per ml), low (10 to 30 ng/ml), normal (30 to 100 ng/
ml) or toxic level (> 100 ng/ml) based on the analysis of 
the blood (26, 27). 
Data were analyzed using the statistical packages for 
social sciences (SPSS) version 16.0 (Chicago, IL, USA). 
Independent t-test and chi square tests were performed 
and any association was considered significant at an 
alpha level of ≤0.05. The parents were informed about 
if their children found to have below or above normal 
serum vitamin D levels.
Results
There was no statistically significant difference between 
the cases and control groups based on age and gender of 
the study participants. However, there was a statistically 
significant difference (P < 0.001) in serum vitamin D 
levels between the cases and the control groups (Table 
1). 
The serum vitamin D level of 21.6% children in the 
cases (ADHD) group was normal. The remaining 78.4% 
children had serum vitamin D level below normal. In the 
control group, 48.6% of the children had normal serum 
vitamin D level. None of the children in both groups 
showed toxic level of vitamin D. Analysis has shown 
a statistically significant difference (P=0.04) in serum 
vitamin D levels between the ADHD and the control 
groups (Table 2). 
Furthermore, there was no a statistically significant 
difference (P=0.3) in serum vitamin D level between 
boys and girls (21.25±11.52 vs. 21.25±11.52) in the 
ADHD group of children. Similarly, there was no a 
statistically significant difference (P=0.9) in the serum 
vitamin D level of boys and girls (28.71±13.22 vs. 
28.63±14.61) in the control group. Besides, there was no 
Vitamin D level and ADHD
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feeding. These studies assume that the nutrient contents 
of breast milk such as vitamins, minerals, etc. may act as 
protective agents. However, there is a need for further 
investigations (35-38). Various studies have examined 
the effects of micronutrients such as iron, zinc and omega 
3 on ADHD, but there is limited evidence suggesting the 
association between vitamin D deficiency and ADHD. 
Thus, further studies seem necessary (14-19, 39). 
Although little research has implicated the relationship 
between ADHD and vitamin D, extensive studies have 
investigated the role of this vitamin in other psychiatric/
neurologic disorders (40, 41) including Alzheimer’s 
disease (42) depression (43, 44), schizophrenia (45) and 
autism (46).
Since vitamin D is a neurosteroid, lack of this vitamin 
results in many psychological disorders (20). In addition, 
vitamin D plays a protective role in brain health, that is, 
it increases the expression of transpeptidasec-glutamyl. 
This enzyme enhances the formation of glutathione, 
which is the most important brain antioxidant factor (47). 
Lack of this vitamin during the fetal life and childhood, in 
the very early days of life affect the nerve differentiation, 
axon synapses, brain structure, and function (20). 
In the present research, although a considerably high 
percentage of children in the ADHD had vitamin D 
deficiency, healthy children in the control was also 
found to have suffered from vitamin D deficiency. 
Vitamin D deficiency is a worldwide epidemic. Despite 
the abundance of sunlight, the prevalence of vitamin D 
deficiency in countries located around the Persian Gulf 
region is high. Findings indicated that 70% of very 
young girls in Iran and 80% in Saudi Arabia suffered 
from vitamin D deficiency (48). Exposure to sunlight 
alone is not sufficient to alleviate vitamin D deficiency 
despite sun light plays a role in maintaining vitamin D 
level in blood (49). 
In conclusion, the low levels of serum vitamin D among 
the ADHD children suggest the need for regularly 
monitoring of serum vitamin D levels and treatment of 
patients with vitamin D deficiencies. In addition, life 
style and diet should be modified and directed towards 
eliminating the nutritional deficiencies in the society.
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Discussion
The results of the present study indicated that the 
proportion of children with vitamin D deficiency in 
ADHD group was significantly larger than that of the 
normal children. In addition, the mean value of serum 
vitamin D level in the cases group (19.11±10.10) was 
significantly lower than in the control (healthy) group 
(28.67±13.76). This finding is consistent with the report 
of a similar study conducted in Turkey among 7 to 18 
years old children where a significant difference (P 
< 0.05) in mean serum vitamin D level between cases 
(20.9±19.4 ng/ml) and control groups (34.9±15.4 ng/
ml) was demonstrated (28). Another study on 1331 
cases of ADHD and the same number of control groups 
healthy individuals under the age of 18 found out that the 
mean range serum vitamin D level of ADHD children 
(16.6±7.8 ng/ml) was lower than in the control group 
(23.5±9.9 ng/ml). In addition, 8.15% of the ADHDs 
had normal vitamin levels in their serum (29). These 
results are also similar to what was found in our study as 
previously stated.
In an interventional study on 80 patients with ADHD 
above the age of 16 in New Zealand, reported 27% 
prevalence rate of vitamin D deficiency. Using vitamin 
D supplement for eight weeks was found to be effective 
in alleviating the signs of the disease. However, adding 
other micronutrients such as zinc, vitamin B12, iron and 
folate was not found effective (30). In contrast, another 
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level (32).
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Table 1. Comparison of the relationship of sex, age and Vitamin D levels (ng/ml) with ADHD and Control groups
Variables
Condition
Gender Age (yr) Vitamin D level (ng/ml)
Boy Girl Mean SD Mean SD
ADHD 23 (62%) 14 (38.7%) 9.13 2.37 19.11 10.10
Control 18 (48.6%) 19 (51.4%) 9.40 2.19 28.67 13.76
Total 41 (55.4%) 33 (44.6%) 9.27 2.27 23.89 12.92
P 0.2 0.6 0.001
Table 2. Comparison of serum vitamin D levels of ADHD and control groups
Variables
Condition







ADHD 11 (29.7) 18 (48.6) 8 (26.1)
Control 6 (16.2) 13 (35.1) 18 (48.6)
Total 17 (23) 31 (41.9) 26 (35.1)
P 0.04
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